Clinical Trial Update: Evaluating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of BIIB054 in Participants With Parkinson's Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating BIIB054 in Parkinson's disease was terminated; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• BIIB054 (BIIB054)

Snippet

Sponsor: Biogen | Conditions: Parkinson's Disease | Phase 2 | Status: TERMINATED | Results posted: 2021-11-23